dihexa approval status fda 10MG : COA Tested Research peptide Dihexa Peptide in Austin, TX

Pharmacokinetic studies demonstrated approximately 38% oral bioavailability and blood-brain barrier penetration, unusual for a peptide-based compound and attributable to Dihexa's small size (504.66 Da) and hydrophobic modifications

This is part of what makes peptides so appealing compared to typical pharmaceuticals: Many of the most common peptides used for medicinal purposes today (like for weight loss, diabetes, and hormone issues) are sequenced directly from peptides in our bodies

10.1016/j.thromres.2011.07.035 135 StupnisekM.KokotA.DrmicD.Hrelec PatrljM.Zenko SeverA.KolencD.et al (2015)

The peptide's anti-inflammatory effects complement its synaptogenic properties, as chronic neuroinflammation actively disrupts synaptic function and prevents formation of new synapses